YOLFTbeta
Guangzhou Jet Bio-Filtration Co Ltd

Guangzhou Jet Bio-Filtration Co Ltd

688026 · SHG · Healthcare / Medical Instruments & Supplies

23.08CNY-2.31 (-9.10%)

Price History

Full chart

Market Stats

Previous Close25.39
Open25.00
Day Range22.97 – 25.82
52-Week Range11.19 – 28.33
Volume9.53M
Market Cap3.88B
P/E (TTM)172.56
Forward P/E0.00
EPS0.16
Dividend Yield0.27%
Beta0.63
50-Day Avg19.24
200-Day Avg16.97

About

Guangzhou Jet Bio-Filtration Co., Ltd. researches, develops, manufactures, and sells biological laboratory consumable products. Its products include bioprocess, biological culture, liquid handling and storage, filtration, molecular biology, cellsafe, medical consumables, biological reagents, medical devices, laboratory instruments, and customization services. The company was founded in 2001 and is headquartered in Guangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Jianhua Yuan
  • Employees1.03K
  • HeadquartersNo. 1 Doutang Road, Guangzhou, China, 511356, China
  • Websitehttps://www.jetbiofil.com

Leadership

  • Mr. Jianhua YuanChairman & Chief Scientist · b. 1952
  • Mr. Ye YuanGM & Director · b. 1979
  • Mr. Xiangyuan FangChief Engineer, Engineering Department Manager & Director of the R&D Center · b. 1972
  • Ms. Jing HeDeputy GM & Director · b. 1988
  • Mr. Feng XieChief Financial Officer · b. 1980
  • Yong An WuAccounting Officer
  • Mr. Zhiyi WuDeputy General Manager · b. 1974
  • Ms. Huilun LiDeputy General Manager · b. 1981

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue70.02M88.26M102.79M124.02M167.04M207.48M247.50M503.93M855.66M609.82M463.10M558.66M565.36M
Growth (%)-+26.05%+16.45%+20.66%+34.69%+24.21%+19.29%+103.61%+69.80%-28.73%-24.06%+20.63%+1.20%
Cost of Revenue37.54M55.99M60.72M70.20M91.10M115.79M136.86M270.54M497.02M415.64M321.29M327.30M504.05M
Gross Profit32.48M32.28M42.06M53.82M75.94M91.69M110.64M233.40M358.64M194.18M141.81M231.36M61.31M
Gross Margin46.38%36.57%40.92%43.40%45.46%44.19%44.70%46.32%41.91%31.84%30.62%41.41%10.84%
Operating Expense19.69M26.58M29.01M29.34M32.46M30.51M34.20M85.22M147.73M98.09M102.37M135.62M0
Operating Income12.79M5.69M13.05M24.48M43.48M61.17M76.44M148.17M210.91M96.09M39.44M95.73M61.31M
Operating Margin18.27%6.45%12.70%19.74%26.03%29.48%30.89%29.40%24.65%15.76%8.52%17.14%10.84%
EBITDA17.46M13.94M24.55M34.04M49.57M71.71M88.38M169.96M248.79M174.27M97.95M167.77M119.68M
EBITDA Margin24.93%15.79%23.88%27.44%29.67%34.56%35.71%33.73%29.08%28.58%21.15%30.03%21.17%
Net Income13.56M8.15M13.43M26.07M40.36M52.83M66.15M119.37M171.16M87.71M34.79M72.19M48.21M
Net Income Margin19.36%9.23%13.07%21.02%24.16%25.47%26.73%23.69%20.00%14.38%7.51%12.92%8.53%
R&D6.10M--7.62M7.87M8.64M12.56M23.90M43.84M37.34M28.51M26.25M29.12M
R&D as % of Total Revenue8.71%--6.15%4.71%4.16%5.08%4.74%5.12%6.12%6.16%4.70%5.15%
Interest Expense914.37K2.34M2.82M1.66M937.10K271.80K183.54K71.44K1.28M13.00M24.91M26.61M28.25M
Interest Expense % of Total Revenue1.31%2.65%2.74%1.34%0.56%0.13%0.07%0.01%0.15%2.13%5.38%4.76%5.00%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets124.41M158.29M185.95M201.54M229.82M328.22M397.37M969.71M1.18B1.61B1.63B1.70B1.74B
Total Liabilities42.37M68.11M66.50M55.87M44.03M46.26M49.26M172.82M208.64M465.21M468.46M504.98M516.17M
Total Equity82.04M90.19M119.45M145.57M185.92M281.96M348.11M796.89M971.82M1.14B1.16B1.19B1.22B
Cash4.69M5.55M7.04M19.86M19.34M32.38M46.08M330.44M263.47M598.88M539.13M284.21M347.75M
Total Debt22.00M39.00M38.25M21.00M---12.28M47.17M321.92M340.20M360.27M-
Net Debt17.31M33.45M31.21M1.14M-19.34M-32.38M-46.08M-318.16M-216.30M-276.96M-198.93M76.06M34.73M

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow18.38M15.67M13.63M33.43M46.67M45.12M61.02M187.57M221.38M166.19M134.81M53.95M191.76M
Investing Cash Flow-37.42M-27.00M-24.57M-2.77M-24.25M-72.16M-45.97M-223.70M-281.52M-485.70M-67.43M-261.74M-
Financing Cash Flow21.37M12.18M12.26M-18.85M-21.87M39.48M-2.39M328.96M-906.69K354.06M-17.95M-38.31M-
Capital Expenditure37.42M27.01M13.67M9.79M12.50M26.48M55.17M250.89M278.92M173.19M183.72M110.67M124.05M
Free Cash Flow-19.04M-11.35M-37.06K23.64M34.17M18.65M5.85M-63.32M-57.54M-7.00M-48.91M-56.72M67.71M
Dividends Paid914.37K4.82M2.82M1.60M870.36K12.49M-50.00M12.27M60.00M11.32M12.32M14.45M
FCF to OCF-103.60%-72.43%-0.27%70.72%73.22%41.32%9.58%-33.76%-25.99%-4.21%-36.29%-105.12%35.31%
Dividend Paid to FCF-4.80%-42.49%-7607.30%6.75%2.55%66.98%--78.96%-21.33%-856.82%-23.14%-21.72%21.34%

Earnings

Report DateMar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Apr 30, 2021Aug 20, 2021Oct 29, 2021Feb 25, 2022Apr 29, 2022Aug 30, 2022Oct 28, 2022Dec 31, 2022Apr 27, 2023
EPS Estimate-------------
EPS Actual0.240.550.14-0.070.340.320.420.140.290.480.110.02-0.06
Surprise-------------
Timing----After-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hours-Pre-market

Key Statistics & Ratios

Market Cap3.88B
Enterprise Value3.84B
Trailing P/E172.56
Forward P/E0.00
Price / Sales6.76
Price / Book3.26
EPS0.16
Book Value8.80
Revenue (TTM)573.29M
Gross Profit (TTM)228.08M
EBITDA145.59M
Profit Margin3.96%
Operating Margin22.33%
Return on Equity1.93%
Return on Assets3.15%
Shares Outstanding140.36M
Shares Float69.13M
Beta0.63
Dividend Yield0.27%
Dividend Rate0.07
Payout Ratio0.00%

Dividends

20261×
0.07Jul 31, 2026
20251×
0.07Jul 2, 2025
20241×
0.07Jul 4, 2024
20231×
0.07Jun 6, 2023
20221×
0.60Jun 8, 2022
20211×
0.09Jul 30, 2021
20201×
0.36Jun 4, 2020

Stock Splits

  • Jun 8, 20221.4:1